Objectives: The purpose of this prospective registry was to evaluate the safety and efficacy,
at 1 year, of the use of drug-eluting balloons (DEB) for the treatment of superficial femoral …

Objectives: The aim of this prospective registry was to evaluate the safety and efficacy at 2-
year follow-up of the use of drug-eluting balloons (DEBs) for the treatment of superficial …

Background—Drug-coated balloon angioplasty (DCBA) was shown to be superior to
standard balloon angioplasty (POBA) in terms of restenosis prevention for de novo …

Background Paclitaxel‐eluting balloon (PEB) angioplasty has superior efficacy compared
with conventional balloon angioplasty (BA) for de novo lesions of superficial femoral artery …

Objectives: This study sought to compare paclitaxel-eluting balloon (PEB) with conventional
percutaneous transluminal angioplasty (PTA), followed by systematic implantation of a self …

Purpose: To investigate the efficacy and sustainability of drug-coated balloon (DCB)
treatment of femoropopliteal in-stent restenosis (ISR). Materials and Methods: An …

Objectives: This study sought to evaluate the safety and effectiveness of a paclitaxel-coated
drug-coated balloon (DCB) for the treatment of patients with de novo in-stent restenosis …

Peripheral artery disease (PAD) is an emerging problem especially with aging population
and increase in the incidence of diabetes and metabolic syndrome. The disease is …

Background: Recent randomized trials investigating stent implantation compared with
balloon angioplasty for treatment of superficial femoral artery (SFA) disease have given …

Purpose: To evaluate the short-and midterm outcomes of the Viabahn endoprosthesis with
Propaten Bioactive Surface vs. standard balloon angioplasty for treatment of in-stent …